SRx Health Solutions receives notice from NYSE American, must regain compliance by July 14, 2026.
PorAinvest
viernes, 17 de octubre de 2025, 8:05 am ET1 min de lectura
SRXH--
The company has been given until November 13, 2025, to submit a plan detailing the actions it will take to regain compliance with the Exchange's continued listing standards by the Plan Period Deadline of July 14, 2026. The receipt of the notice has no immediate effect on the listing or trading of SRx Health's common stock on the Exchange, nor does it impact the company's business operations or reporting requirements with the U.S. Securities and Exchange Commission.
Forward-looking statements included in the press release highlight the company's current expectations and projections about future events and financial trends. However, it is important to note that some or all of the results anticipated by these forward-looking statements may not be achieved.
SRx Health Solutions, Inc. has until November 13, 2025, to submit a plan of action to address the compliance issue. The company's Chief Executive Officer, Kent Cunningham, and Investor Contact, Valter Pinto, are available for further information.
• SRx Health Solutions received notice from NYSE American LLC for non-compliance.
• Company must have $4 million in stockholders' equity by July 2026.
• SRx Health has until November 13, 2025, to submit a plan of action.
• Receipt of notice has no immediate effect on listing or trading.
SRx Health Solutions, Inc. (NYSE American: SRXH) has received a notice from NYSE American LLC indicating that the company is not in compliance with the exchange's continued listing standards under Section 1003(a)(ii) of the NYSE American Company Guide, according to a GlobeNewswire release https://www.globenewswire.com/news-release/2025/10/17/3168585/0/en/SRx-Health-Solutions-Received-NYSE-American-Notification-Letter-Regarding-Stockholders-Equity-Deficiency.html. The notice, detailed in the notification letter https://www.stocktitan.net/news/SRXH/s-rx-health-solutions-received-nyse-american-notification-letter-u2lwu0ml57xt.html, was received on October 17, 2025, and specifies that the company must have stockholders' equity of $4 million or more if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years.The company has been given until November 13, 2025, to submit a plan detailing the actions it will take to regain compliance with the Exchange's continued listing standards by the Plan Period Deadline of July 14, 2026. The receipt of the notice has no immediate effect on the listing or trading of SRx Health's common stock on the Exchange, nor does it impact the company's business operations or reporting requirements with the U.S. Securities and Exchange Commission.
Forward-looking statements included in the press release highlight the company's current expectations and projections about future events and financial trends. However, it is important to note that some or all of the results anticipated by these forward-looking statements may not be achieved.
SRx Health Solutions, Inc. has until November 13, 2025, to submit a plan of action to address the compliance issue. The company's Chief Executive Officer, Kent Cunningham, and Investor Contact, Valter Pinto, are available for further information.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios